
Glimfirst-M2 Forte 2mg/1000mg Tablet SR
Marketer
Sinsan Pharmaceuticals
Salt Composition
Glimepiride (2mg) + Metformin (1000mg)
Overview Glimfirst-M2 Forte 2mg/1000mg Tablet SR
Diabexe Duo 2mg/1000mg Extended-Release Tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. This formulation helps regulate blood glucose levels. Diabexe Duo should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood glucose monitoring. Continued use, even with controlled blood sugar, is crucial. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be minimized due to its potential to worsen hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests (including blood cell counts and liver function) are recommended.
Uses of Glimfirst-M2 Forte 2mg/1000mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimfirst-M2 Forte 2mg/1000mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimfirst-M2 Forte 2mg/1000mg Sustained-Release tablets should be administered with a meal.
Common Side effects of Glimfirst-M2 Forte 2mg/1000mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimfirst-M2 Forte 2mg/1000mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Glimfirst-M2 Forte 2mg/1000mg Sustained-Release tablet should be swallowed whole with food; do not break, crush, or chew it.
How Glimfirst-M2 Forte 2mg/1000mg Tablet SR works:
Glimepiride/Metformin 2mg/1000mg extended-release tablets (Glimfirst-M2 Forte) combine two distinct anti-diabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts triply by decreasing hepatic glucose production, impeding intestinal glucose uptake, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimfirst-M2 Forte 2mg/1000mg SR tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimfirst-M2 Forte 2mg/1000mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
The extended-release Glimfirst-M2 Forte 2mg/1000mg tablet is contraindicated during lactation. Evidence indicates a potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimfirst-M2 Forte 2mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of this medication. Regular kidney function monitoring is recommended during treatment. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimfirst-M2 Forte 2mg/1000mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; however, the medication is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimfirst-M2 Forte 2mg/1000mg Tablet SR :
Should you forget a dose of Glimfirst-M2 Forte 2mg/1000mg Sustained-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimfirst-M2 Forte 2mg/1000mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Treatment |
